SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-015679
Filing Date
2024-05-09
Accepted
2024-05-09 16:11:46
Documents
92
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20240331_10q.htm   iXBRL 10-Q 1852798
2 EXHIBIT 31.1 ex_664757.htm EX-31.1 7881
3 EXHIBIT 31.2 ex_664758.htm EX-31.2 8213
4 EXHIBIT 32.1 ex_664759.htm EX-32.1 3905
5 EXHIBIT 32.2 ex_664760.htm EX-32.2 3886
  Complete submission text file 0001437749-24-015679.txt   10687632

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nby-20240331.xsd EX-101.SCH 93423
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20240331_cal.xml EX-101.CAL 54859
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20240331_def.xml EX-101.DEF 590434
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20240331_lab.xml EX-101.LAB 504346
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20240331_pre.xml EX-101.PRE 632828
96 EXTRACTED XBRL INSTANCE DOCUMENT nby20240331_10q_htm.xml XML 2225658
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 24930715
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)